CAMP4 Therapeutics Corporation
CAMP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -46.9% | 74.5% | 31.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $1 | $1 | $1 |
| % Margin | 47.7% | 100% | 100% | 100% |
| R&D Expenses | $9 | $10 | $10 | $10 |
| G&A Expenses | $5 | $4 | $4 | $5 |
| SG&A Expenses | $5 | $4 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $15 | $14 | $15 |
| Operating Income | -$13 | -$13 | -$13 | -$14 |
| % Margin | -1,655% | -870.3% | -1,526.8% | -2,152.5% |
| Other Income/Exp. Net | -$2 | $0 | $1 | $1 |
| Pre-Tax Income | -$15 | -$13 | -$12 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15 | -$13 | -$12 | -$13 |
| % Margin | -1,899.2% | -840.8% | -1,449.1% | -2,036.7% |
| EPS | -0.55 | -0.62 | -0.64 | -0.68 |
| % Growth | 11.3% | 3.1% | 5.9% | – |
| EPS Diluted | -0.55 | -0.62 | -0.64 | -0.68 |
| Weighted Avg Shares Out | 20 | 20 | 20 | 20 |
| Weighted Avg Shares Out Dil | 20 | 20 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$15 | -$13 | -$13 | -$14 |
| % Margin | -1,846.9% | -841.5% | -1,477.7% | -2,088.3% |